Last edition
News about "Vanda Pharmaceuticals "
Vanda Pharmaceuticals Receives Orphan Drug Designation Granted for VGT-1849A
VGT-1849A is a novel ASO treatment candidate for PV and other JAK2-driven hematologic malignancies.
Vanda Pharmaceuticals | 21/12/2024 | By Aishwarya
Cycle Pharmaceuticals Offers All-Cash Proposal to Acquire Vanda Pharmaceuticals
Cycle Pharmaceuticals Ltd. has confirmed that it proposed to the Board of Directors of Vanda Pharmaceuticals, Inc. to acquire 100 percent of Vanda’s issued and outstanding shares for a cash consideration of USD 8.00 per Vanda share.
Vanda Pharmaceuticals | 07/06/2024 | By Aishwarya | 230
Vanda Fanapt Receives FDA Approval for Acute Treatment of Bipolar I Disorder
Vanda Pharmaceuticals Inc. has announced that the US FDA has approved Fanapt (iloperidone) tablets for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults.
Vanda Pharmaceuticals | 03/04/2024 | By Aishwarya | 145
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy